Janelle Bradley

Conference Coverage
Workload Index Proves Valuable in Optimizing Oncology Advanced Practitioner Resourcing
11/18/2024
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success of the workload index in supporting daily and longitudinal staffing needs as well as for operational and strategic planning and has improved advanced practitioner morale by demonstrating productivity not...
Findings demonstrate the success...
11/18/2024
APP Institute Oncology
News
Treatment for Metastatic Castration-Resistant Prostate Cancer: Real-World vs CARD Study
02/08/2022
Study findings suggest that the CARD study population is reflective of real-world clinical practice and that sequential use of androgen-receptor-targeted agents before chemotherapy initiation is common.
Study findings suggest that the CARD study population is reflective of real-world clinical practice and that sequential use of androgen-receptor-targeted agents before chemotherapy initiation is common.
Study findings suggest that the...
02/08/2022
Journal of Clinical Pathways
Conference Coverage
Lenalidomide and Obinutuzumab Plus CHOP Yields High Rate of Undetectable MRD in DLBCL
06/08/2022
Lenalidomide and obinutuzumab combined with CHOP demonstrates promising efficacy and tolerability in DLBCL, yielding a high rate of undetectable MRD by ctDNA, according to findings from a phase 1b/2 study.
Lenalidomide and obinutuzumab combined with CHOP demonstrates promising efficacy and tolerability in DLBCL, yielding a high rate of undetectable MRD by ctDNA, according to findings from a phase 1b/2 study.
Lenalidomide and obinutuzumab...
06/08/2022
Oncology
Conference Coverage
Trastuzumab Deruxtecan Doubles PFS vs Standard Chemotherapy in HER2-Low Metastatic Breast Cancer
06/05/2022
Trastuzumab deruxtecan doubled PFS vs standard chemotherapy in patients with chemotherapy in patients with metastatic breast cancer and low HER2 expression levels, according to findings from the DESTINY-Breast04 trial.
Trastuzumab deruxtecan doubled PFS vs standard chemotherapy in patients with chemotherapy in patients with metastatic breast cancer and low HER2 expression levels, according to findings from the DESTINY-Breast04 trial.
Trastuzumab deruxtecan doubled...
06/05/2022
Oncology
Conference Coverage
Reconfiguration and Consolidation Trends and Their Impact on Oncology
03/05/2022
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought together consultants and leaders to discuss industry reconfiguration and consolidation trends and their impact on oncology.
A session at the ACCC 48th Annual Meeting and Cancer Center Business Summit brought together consultants and leaders to discuss industry reconfiguration and consolidation trends and their impact on oncology.
A session at the ACCC 48th...
03/05/2022
Journal of Clinical Pathways
News
Betibeglogene Autotemcel Enables Transfusion-Independence for Patients With Beta-Thalassemia
09/21/2022
Treatment with betibeglogene autotemcel enables transfusion independence for patients with non–β0/β0 genotype transfusion-dependent beta-thalassemia, according to findings from the ongoing phase 3 Northstar-2 trial.
Treatment with betibeglogene autotemcel enables transfusion independence for patients with non–β0/β0 genotype transfusion-dependent beta-thalassemia, according to findings from the ongoing phase 3 Northstar-2 trial.
Treatment with betibeglogene...
09/21/2022
Oncology
Conference Coverage
Combination Chemotherapy and Tumor Treating Fields Improve OS in Patients With Recurrent Glioblastoma
06/15/2023
Combination treatment using tumor treating fields with temozolomide, bevacizumab, and irinotecan chemotherapy improves OS in patients with recurrent glioblastoma with manageable safety.
Combination treatment using tumor treating fields with temozolomide, bevacizumab, and irinotecan chemotherapy improves OS in patients with recurrent glioblastoma with manageable safety.
Combination treatment using...
06/15/2023
Oncology
Conference Coverage
Oncologists’ Perspectives on Patient-centered Dosing for Metastatic Breast Cancer
12/06/2021
Medical oncologists reported that a high percentage of patients experience distressing toxicity, a need for acute care, and dose interruptions with standard delivery of therapy for metastatic breast cancer.
Medical oncologists reported that a high percentage of patients experience distressing toxicity, a need for acute care, and dose interruptions with standard delivery of therapy for metastatic breast cancer.
Medical oncologists reported...
12/06/2021
Journal of Clinical Pathways
Conference Coverage
Real-World Treatment Patterns and Decision-Making for Patients With MM in the United States
12/08/2021
Study results presented at the 2021 ASH Annual Meeting provided valuable real-world data on current treatment patterns and decision-making for patients with MM.
Study results presented at the 2021 ASH Annual Meeting provided valuable real-world data on current treatment patterns and decision-making for patients with MM.
Study results presented at the...
12/08/2021
Journal of Clinical Pathways
NCCN Updates Clinical Practice Guideline for Esophageal Cancers
NCCN Updates Clinical Practice Guideline for Esophageal Cancers
03/10/2021
The National Comprehensive Cancer Network released an update to its clinical practice guideline for esophageal and esophageal junction cancers.
The National Comprehensive Cancer Network released an update to its clinical practice guideline for esophageal and esophageal junction cancers.
The National Comprehensive...
03/10/2021
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use